Pregnancy Weight Gain

2

Review clinical trials related to Pregnancy Weight Gain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women

The purpose of this study is to compare the effectiveness of H42-HV integrated into home visiting compared with usual home visiting services in reducing postpartum weight retention (difference between pre-pregnancy weight and weight at 6 months postpartum) among pregnant and postpartum participants. The overall goal is to improve long-term cardiometabolic health.

Participants needed: 360
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Pregnant, ≤33 weeks gestation [+6]

Type 1 diabetes or taking insulin prior to delivery [+7]

Status: Recruiting

Time-restricted Eating Among Pregnant Females With Severe Obesity

In the United States, a body mass index (BMI) of at least 35.0 kg/m2 affects about 15% of women of reproductive age. Severe obesity is a significant predictor of adverse perinatal outcomes including gestational diabetes mellitus, pre-eclampsia, premature birth, and at its most severe, fetal death, birth defects and a three-fold greater risk of maternal mortality. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. The proposed research aims to assess time-restricted eating in the 2nd and 3rd trimesters of pregnancy to explore the effects on maternal weight, and perinatal health outcomes compared to standard clinical care.

Participants needed: 60
Trial details
Age: 18-44Biological sex: FemaleType: InterventionalSponsor: University of Illinois at ChicagoUpdated: Jan 23, 2026Locations: 1
Eligibility criteria

Female based on sex assigned at birth [+8]

Deemed medically high risk [+12]